Bharat Biotech’s Nasal Vaccine iNCOVACC To Cost Rs 800: Sources
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
- Latest
- Trending
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
New Delhi: Bharat Biotech, which has a stockpile of more than 50 million doses of Covaxin ready to be distributed ...
Hyderabad: The World Health Organization (WHO) is a step closer to granting an emergency use listing (EUL) to Covaxin after ...
Bhubaneswar: Odisha on Tuesday received 1,11,100 doses of state-procured Covaxin vaccine. The consignment reached Bhubaneswar in a special flight. The ...
New Delhi: The supply price of COVID-19 vaccine Covaxin to the Central government at Rs 150 per dose is not ...
Patna: Bharat Biotech has started paediatric trials of its COVID-19 vaccine Covaxin at the All India Institute of Medical Sciences ...
New Delhi: The Delhi High Court on Wednesday heard a PIL, to set aside the permission granted by the Drugs ...
New Delhi: COVID-19 vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) will get Rs 1,500 crore and Rs ...
Bhubaneswar: All frontline workers will be vaccinated at their respective workplace, said Director, Health and Family Welfare Bijay Panigrahi here ...
New Delhi: Bharat Biotech's Covaxin is effective against the UK variant of the virus. Taking to Twitter, Bharat Biotech said ...
© 2024 Frontmedia